International Journal of Infectious Diseases
Volume 12, Issue 6 , Pages e99-e105 , November 2008

Bacillus Calmette–Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy

  • James J. Nuttall

      Affiliations

    • Paediatric Infectious Diseases Unit, Red Cross Children's Hospital, School of Child and Adolescent Health, University of Cape Town, Rondebosch, 7700, Cape Town, South Africa
    • Corresponding Author InformationCorresponding author. Tel.: +27 21 6585499; fax: +27 21 6891287.
    • ,
  • Mary-Ann Davies

      Affiliations

    • Paediatric Infectious Diseases Unit, Red Cross Children's Hospital, School of Child and Adolescent Health, University of Cape Town, Rondebosch, 7700, Cape Town, South Africa
    • Infectious Diseases Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, South Africa
    • ,
  • Gregory D. Hussey

      Affiliations

    • Paediatric Infectious Diseases Unit, Red Cross Children's Hospital, School of Child and Adolescent Health, University of Cape Town, Rondebosch, 7700, Cape Town, South Africa
    • South African Tuberculosis Vaccine Institute, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
    • ,
  • Brian S. Eley

      Affiliations

    • Paediatric Infectious Diseases Unit, Red Cross Children's Hospital, School of Child and Adolescent Health, University of Cape Town, Rondebosch, 7700, Cape Town, South Africa

Received 26 February 2008 ,Revised 28 May 2008 ,Accepted 10 June 2008.

References 

  1. Dorrington R, Johnson L, Bradshaw D, Daniel TJ. The demographic impact of HIV/AIDS in South Africa: national and provincial indicators for 2006. South Africa: Centre for Actuarial Research, South African Medical Research Council and the Actuarial Society of South Africa; 2006. Available at: http://www.mrc.ac.za/bod/DemographicImpactHIVIndicators.pdf (accessed August 2008).
  2. Meyers T, Moultrie H, Naidoo K, Cotton M, Eley B, Sherman G. Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis. 2007;196(Suppl 3):S474–S481
  3. Mohamed H, Kibel M, Hawkridge T, Schaaf HS, Hanekom WA, Iloni K, et al. The impact of a change in Bacille Calmette–Guerin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr Infect Dis J. 2006;25:1167–1172
  4. World Health Organization. Revised BCG vaccination guidelines for infants at risk for HIV infection. Wkly Epidemiol Rec. 2007;82:193–196
  5. Lotte A, Wasz-Hockert O, Poisson N, Engbaek H, Landmann H, Quast U, et al. Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull Int Union Tuberc Lung Dis. 1988;63:47–59
  6. Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated Bacille Calmette–Guerin disease after vaccination: case report and review. Clin Infect Dis. 1997;24:1139–1146
  7. Jeena PM, Chhagan MK, Topley J, Coovadia HM. Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban, South Africa. Bull World Health Organ. 2001;79:337–343
  8. Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, et al. Bacille Calmette–Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis. 2006;14:548–558
  9. Fallo A, Torrado L, Sanches A, Cerqueiro C, Schagrodsky L, Lopez EL. Delayed complications of Bacille Calmette–Guerin (BCG) vaccination in HIV-infected children 2005. In: Proceedings of the 3rd IAS conference on HIV pathogenesis and treatment, July 24–27, 2005. Rio de Janeiro, Brazil: International AIDS Society; 2005;
  10. Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PEM, Godfrey-Faussett P, et al. The risk of disseminated Bacille Calmette–Guerin (BCG) disease in HIV-infected children. Vaccine. 2007;25:14–18
  11. Sharp MJ, Mallon DF. Regional bacillus Calmette–Guérin lymphadenitis after initiating antiretroviral therapy in an infant with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J. 1998;17:660–662
  12. Puthanakit T, Oberdorfer P, Punjaisee S, Wannarit P, Sirisanthana T, Sirisanthana V. Immune reconstitution syndrome due to bacillus Calmette–Guérin after initiation of antiretroviral therapy in children with HIV infection. Clin Infect Dis. 2005;41:1049–1052
  13. Kroidl A, Huck K, Weinspach S, Gudowius S, Mackenzie CR, Oette M, et al. Immune reconstitution inflammatory syndrome (IRIS) due to Bacille Calmette–Guerin (BCG) in an HIV-positive child. Scand J Infect Dis. 2006;38:716–718
  14. Alexander A, Rode H. Adverse reactions to the bacillus Calmette–Guerin vaccine in HIV-positive infants. J Pediatr Surg. 2007;42:549–552
  15. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings. 2003 revision. Available at: http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf. (accessed August 2008).
  16. Hesseling AC, Schaaf HS, Hanekom WA, Beyers N, Gie RP, Marais BJ, et al. Danish Bacille Calmette–Guerin vaccine-induced disease in human immunodeficiency virus-infected children. Clin Infect Dis. 2003;37:1226–1233
  17. Roditi D, Lambrick M, Nicol M, Chojnack M, Eley B, Steyn L. The use of PCR to distinguish clinical isolates of BCG from Mycobacterium bovis. Abstract. Presented at the Joint Congress of the Infectious Diseases and Sexually Transmitted Diseases Societies of Southern Africa, December 2001, Stellenbosch, South Africa.
  18. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry. 2002;15:69–77
  19. Shankar EM, Vignesh R, Murugavel KG, Balakrishnan P, Sekar R, Lloyd CA, et al. Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: views over hidden possibilities. AIDS Res Ther. 2007;4:29
  20. Kampmann B, Tena-Coki GN, Levin M, Eley BS. Reconstitution of antimycobacterial immune responses in HIV-infected children receiving HAART. AIDS. 2006;20:1011–1018
  21. Grange JM. Complications of bacille Calmette–Guérin (BCG) vaccination and immunotherapy and their management. Commun Dis Public Health. 1998;1:84–88
  22. Nicol M, Eley B, Kibel M, Hussey G. Intradermal BCG vaccination—adverse reactions and their management. S Afr Med J. 2002;92:39–42

PII: S1201-9712(08)01413-6

doi: 10.1016/j.ijid.2008.06.014

International Journal of Infectious Diseases
Volume 12, Issue 6 , Pages e99-e105 , November 2008

Article Tools

* Image Usage & Resolution